650741319	650741319	CD	B-NP	O
|	|	NN	I-NP	O
CLMC	CLMC	NN	I-NP	O
|	|	NN	I-NP	O
74661276	74661276	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
011050	011050	CD	B-NP	O
|	|	CC	I-NP	O
3/15/2001	3/15/2001	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
CAD	CAD	NN	I-NP	I-protein
,	,	,	O	O
CHF	CHF	NN	B-NP	B-protein
r/o	r/o	NN	I-NP	I-protein
MI	MI	NN	I-NP	I-protein
,	,	,	O	O
sm	sm	NN	B-NP	O
.	.	.	O	O

area	area	NN	B-NP	O
of	of	IN	B-PP	O
inferolat	inferolat	NN	B-NP	O
rev.	rev.	NN	I-NP	O
ischemia	ischemia	NN	I-NP	O
by	by	IN	B-PP	O
adenosine	adenosine	NN	B-NP	O
MIBI	MIBI	NNP	I-NP	O
,	,	,	O	O
EF	EF	NNP	B-NP	O
:	:	:	O	O
45	45	CD	B-NP	O
%	%	NN	I-NP	O
LV	LV	NN	I-NP	O
dilation	dilation	NN	I-NP	O
|	|	NN	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/28/2001	9/28/2001	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
2/7/2001	2/7/2001	CD	B-NP	O
******	******	SYM	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NN	I-NP	O
******	******	SYM	B-VP	O
BARNAS	BARNAS	NN	B-NP	O
,	,	,	O	O
ISSAC	ISSAC	NN	B-NP	O
497-00-49-5	497-00-49-5	CD	I-NP	O
Jervi	Jervi	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
10/1/01	10/1/01	CD	B-NP	O
AT	AT	NN	I-NP	O
01	01	CD	I-NP	O
:	:	:	O	O
30	30	CD	B-NP	O
PM	PM	NN	I-NP	O
CONTINGENT	CONTINGENT	NN	I-NP	O
UPON	UPON	NN	I-NP	O
HO	HO	NN	I-NP	O
evaluation	evaluation	NN	I-NP	O
WILL	WILL	MD	B-VP	O
D/C	D/C	NNP	B-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNS	B-NP	O
CODE	CODE	NN	I-NP	O
STATUS	STATUS	NNS	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
HCTZ	HCTZ	NN	B-NP	B-DNA
-LRB-	-LRB-	NN	I-NP	I-DNA
HYDROCHLOROTHIAZIDE	HYDROCHLOROTHIAZIDE	NN	I-NP	I-DNA
-RRB-	-RRB-	NN	I-NP	I-DNA
25	25	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
QD	QD	NNP	I-NP	I-DNA
ZOCOR	ZOCOR	NNP	I-NP	I-DNA
-LRB-	-LRB-	NNP	I-NP	I-DNA
SIMVASTATIN	SIMVASTATIN	NNP	I-NP	I-DNA
-RRB-	-RRB-	NNP	I-NP	I-DNA
10	10	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
QHS	QHS	NNP	I-NP	I-DNA
Food/Drug	Food/Drug	NNP	I-NP	I-DNA
Interaction	Interaction	NNP	I-NP	I-DNA
Instruction	Instruction	NNP	I-NP	I-DNA
Avoid	Avoid	NNP	I-NP	I-DNA
grapefruit	grapefruit	NN	I-NP	I-DNA
unless	unless	IN	B-SBAR	I-DNA
MD	MD	NN	B-NP	I-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

VIOXX	VIOXX	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ROFECOXIB	ROFECOXIB	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
25	25	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
with	with	IN	B-PP	O
food	food	NN	B-NP	O
ASA	ASA	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	I-NP	O
ACID	ACID	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
81	81	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
ATENOLOL	ATENOLOL	NNP	I-NP	O
12.5	12.5	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QD	QD	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
consistently	consistently	RB	B-ADVP	O
with	with	IN	B-PP	O
meals	meal	NNS	B-NP	O
or	or	CC	B-PP	O
on	on	IN	B-PP	O
empty	empty	JJ	B-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

ZANTAC	ZANTAC	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
RANITIDINE	RANITIDINE	NN	I-NP	I-protein
HCL	HCL	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
150	150	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
BID	BID	NNP	I-NP	I-protein
LISINOPRIL	LISINOPRIL	NNP	I-NP	I-protein
5	5	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
QD	QD	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
10/1/01	10/1/01	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
POTASSIUM	POTASSIUM	NNP	B-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
&	&	CC	I-NP	O
LISINOPRIL	LISINOPRIL	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
ok	ok	NN	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
Activity	Activity	NN	I-NP	O
-	-	HYPH	O	O
As	As	IN	B-SBAR	O
tolerated	tolerate	VBN	B-NP	O
RETURN	RETURN	NNP	I-NP	O
TO	TO	NNP	I-NP	O
WORK	WORK	NNP	I-NP	O
:	:	:	O	O
Not	Not	NNP	B-NP	O
Applicable	Applicable	NNP	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr.	Dr.	NNP	B-NP	O
Brant	Brant	NNP	I-NP	O
Ravo	Ravo	NNP	I-NP	O
1	1	CD	I-NP	O
week	week	NN	I-NP	O
,	,	,	O	O
No	No	NNP	B-NP	O
Known	Known	NNP	I-NP	O
Allergies	Allergies	NNP	I-NP	O
ADMIT	ADMIT	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
:	:	:	O	O
r/o	r/o	NNP	B-NP	O
MI	MI	NNP	I-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
CAD	CAD	NNP	I-NP	O
,	,	,	O	O
CHF	CHF	NNP	B-NP	O
r/o	r/o	NNP	I-NP	O
MI	MI	NNP	I-NP	O
,	,	,	O	O
sm	sm	NN	B-NP	O
.	.	.	O	O

area	area	NN	B-NP	O
of	of	IN	B-PP	O
inferolat	inferolat	NN	B-NP	O
rev.	rev.	NN	I-NP	O
ischemia	ischemia	NN	I-NP	O
by	by	IN	B-PP	O
adenosine	adenosine	NN	B-NP	O
MIBI	MIBI	NNP	I-NP	O
,	,	,	O	O
EF	EF	NNP	B-NP	O
:	:	:	O	O
45	45	CD	B-NP	O
%	%	NN	I-NP	O
LV	LV	NN	I-NP	O
dilation	dilation	NN	I-NP	O
OTHER	OTHER	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
hypertension	hypertension	NN	I-NP	O
hypercholesterolemia	hypercholesterolemia	NN	I-NP	O
obesity	obesity	NN	I-NP	O
lumbosacral	lumbosacral	JJ	I-NP	O
disc	disc	NN	I-NP	O
degeneration	degeneration	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
OTHER	OTHER	NNP	B-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
r/o	r/o	NNP	I-NP	O
MI	MI	NNP	I-NP	O
--	--	:	O	O
ruled	rule	VBD	B-VP	O
out	out	RP	B-PRT	O
adenosine	adenosine	NN	B-NP	O
MIBI	MIBI	NN	I-NP	O
part	part	NN	I-NP	O
I	I	CD	I-NP	O
stress	stress	NN	I-NP	O
--	--	:	O	O
small	small	JJ	B-NP	O
amt	amt	NN	I-NP	O
.	.	.	O	O

inferior/lateral	inferior/lateral	JJ	B-NP	O
defect	defect	NN	I-NP	O
seen	see	VBN	B-VP	O
.	.	.	O	O

Part	Part	NN	B-NP	O
II	II	CD	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
resting	rest	VBG	B-VP	O
-RRB-	-RRB-	NN	B-NP	O
complete	complete	JJ	I-NP	O
3/7	3/7	CD	I-NP	O
Sm	Sm	NN	I-NP	O
.	.	.	O	O

amount	amount	NN	B-NP	O
of	of	IN	B-PP	O
rev.	rev.	NN	B-NP	O
ischemia	ischemia	NN	I-NP	O
inferolateral	inferolateral	JJ	I-NP	O
wall	wall	NN	I-NP	O
,	,	,	O	O
sum	sum	NN	B-NP	O
stress	stress	NN	I-NP	O
score	score	NN	I-NP	O
:	:	:	O	O
4	4	CD	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
4-8	4-8	CD	B-NP	O
is	be	VBZ	B-VP	O
mild	mild	JJ	B-NP	O
abnormal	abnormal	JJ	I-NP	O
test	test	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
echo	echo	NN	B-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
wall	wall	NN	B-NP	O
motion	motion	NN	I-NP	O
abnormality	abnormality	NN	I-NP	O
in	in	IN	B-PP	O
inferolat	inferolat	NN	B-NP	O
.	.	.	O	O

area	area	NN	B-NP	O
,	,	,	O	O
LV	LV	NN	B-NP	O
is	be	VBZ	B-VP	O
dilated	dilate	VBN	I-VP	O
-LRB-	-LRB-	IN	B-PP	O
120	120	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
and	and	CC	O	O
EF	EF	NN	B-NP	O
43	43	CD	B-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

BRIEF	BRIEF	NN	B-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
53	53	CD	B-NP	O
y.o	y.o	NN	I-NP	O
african	african	JJ	I-NP	O
american	american	JJ	I-NP	O
woman	woman	NN	I-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-VP	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
hypercholesteroleia	hypercholesteroleia	NN	B-NP	O
,	,	,	O	O
morbid	morbid	NN	B-NP	O
obesity	obesity	NN	I-NP	O
presents	present	VBZ	B-VP	O
with	with	IN	B-PP	O
1	1	CD	B-NP	O
month	month	NN	I-NP	O
intermittent	intermittent	JJ	I-NP	O
chest	chest	NN	I-NP	O
pressure	pressure	NN	I-NP	O
sometimes	sometimes	RB	B-VP	O
associated	associate	VBN	I-VP	O
with	with	IN	B-PP	O
sob	sob	NN	B-NP	B-protein
,	,	,	O	O
diaphoresis	diaphoresis	NN	B-NP	O
.	.	.	O	O

Pressure	Pressure	NN	B-NP	O
sensation	sensation	NN	I-NP	O
became	become	VBD	B-VP	O
more	more	RBR	B-ADJP	O
frequent	frequent	JJ	I-ADJP	O
--	--	:	O	O
once	once	RB	B-ADVP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
for	for	IN	B-PP	O
the	the	DT	B-NP	O
past	past	JJ	I-NP	O
week	week	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
now	now	RB	B-VP	O
radiates	radiate	VBZ	I-VP	O
to	to	TO	I-VP	O
left	left	VB	I-VP	O
arm	arm	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
n/v/f	n/v/f	NN	I-NP	B-protein
/	/	SYM	B-NP	O
c/orthopnea/doe	c/orthopnea/doe	NN	I-NP	O
.	.	.	O	O

At	At	IN	B-PP	O
baseline	baseline	NN	B-NP	O
,	,	,	O	O
has	have	VBZ	B-VP	O
short	short	JJ	B-NP	O
walking	walk	VBG	I-NP	O
tolerance	tolerance	NN	I-NP	O
.	.	.	O	O

Was	Be	VBD	B-VP	O
late	late	RB	B-ADVP	O
for	for	IN	B-PP	O
pot	pot	NN	B-NP	O
medical	medical	JJ	I-NP	O
center	center	NN	I-NP	O
appt	appt	NN	I-NP	O
.	.	.	O	O

today	today	NN	B-NP	O
--	--	:	O	O
was	be	VBD	B-VP	O
sent	send	VBN	I-VP	O
to	to	TO	B-VP	O
ED	ED	VBN	I-VP	O
for	for	IN	B-PP	O
r/o	r/o	NN	B-NP	O
.	.	.	O	O

CK	CK	NN	B-NP	B-protein
79	79	CD	I-NP	I-protein
,	,	,	O	O
TnI	TnI	NN	B-NP	O
0.0	0.0	CD	I-NP	O
and	and	CC	O	O
EKG	EKG	NN	B-NP	B-protein
with	with	IN	B-PP	O
t	t	NN	B-NP	O
wave	wave	NN	I-NP	O
inversions	inversion	NNS	I-NP	O
v5-6	v5-6	NN	I-NP	B-protein
,	,	,	O	O
inverted	invert	VBN	B-NP	O
P	P	NN	I-NP	O
waves	wave	VBZ	B-VP	O
v1-2	v1-2	NN	B-NP	B-protein
of	of	IN	B-PP	O
unclear	unclear	JJ	B-NP	O
significance	significance	NN	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
.	.	.	O	O

ruled	rule	VBN	B-VP	O
out	out	RP	B-PRT	O
for	for	IN	B-PP	O
MI	MI	NN	B-NP	O
by	by	IN	B-PP	O
enzymes	enzyme	NNS	B-NP	B-protein
,	,	,	O	O
and	and	CC	O	O
had	have	VBD	B-VP	O
adenosine	adenosine	NN	B-NP	O
mibi	mibi	NNS	I-NP	O
and	and	CC	O	O
echo	echo	NN	B-NP	O
.	.	.	O	O

MIBI	MIBI	NN	B-NP	O
showed	show	VBD	B-VP	O
sm	sm	NN	B-NP	O
.	.	.	O	O

amt	amt	NN	B-NP	O
.	.	.	O	O

of	of	IN	B-PP	O
inferolateral	inferolateral	JJ	B-NP	O
reversible	reversible	JJ	I-NP	O
ischemia	ischemia	NN	I-NP	O
,	,	,	O	O
sum	sum	NN	B-NP	B-protein
stress	stress	NN	I-NP	I-protein
score	score	NN	I-NP	I-protein
4	4	CD	I-NP	I-protein
-LRB-	-LRB-	HYPH	I-NP	I-protein
4-8	4-8	CD	I-NP	I-protein
mild	mild	JJ	I-NP	I-protein
abnl	abnl	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
,	,	,	B-PP	O
and	and	CC	I-PP	O
on	on	IN	B-PP	O
echo	echo	NN	B-NP	O
,	,	,	O	O
there	there	EX	B-NP	O
is	be	VBZ	B-VP	O
hypokinesis	hypokinesis	NN	B-NP	O
of	of	IN	B-PP	O
inferolateral	inferolateral	JJ	B-NP	O
wall	wall	NN	I-NP	O
.	.	.	O	O

LV	LV	NN	B-NP	O
is	be	VBZ	B-VP	O
dilated	dilate	VBN	I-VP	O
,	,	,	O	O
EF	EF	NN	B-NP	O
45	45	CD	I-NP	O
%	%	NN	I-NP	O
.	.	.	O	O

Etiology	Etiology	NN	B-NP	O
of	of	IN	B-PP	O
cardiomyopathy	cardiomyopathy	NN	B-NP	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
cardiologist	cardiologist	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
because	because	IN	B-SBAR	O
the	the	DT	B-NP	O
area	area	NN	I-NP	O
of	of	IN	B-PP	O
reversible	reversible	JJ	B-NP	O
ischemia	ischemia	NN	I-NP	O
was	be	VBD	B-VP	O
so	so	RB	B-ADJP	O
small	small	JJ	I-ADJP	O
,	,	,	O	O
she	she	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
medically	medically	RB	I-VP	O
managed	manage	VBN	I-VP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
.	.	.	O	O

started	start	VBN	B-VP	O
on	on	IN	B-PP	O
ACEI	ACEI	NN	B-NP	B-protein
,	,	,	O	O
ASA	ASA	NN	B-NP	O
,	,	,	O	O
zocor	zocor	NN	B-NP	O
,	,	,	O	O
atenolol	atenolol	NN	B-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
12.5	12.5	CD	I-NP	O
mg	mg	NN	I-NP	O
dose	dose	NN	I-NP	O
chosen	chosen	NN	I-NP	O
b/c	b/c	NN	I-NP	O
pt	pt	NN	I-NP	O
.	.	.	O	O

has	have	VBZ	B-VP	O
had	have	VBN	I-VP	O
HR	HR	NN	B-NP	B-DNA
64	64	CD	I-NP	I-DNA
and	and	CC	O	O
pressures	pressure	NNS	B-NP	O
in	in	IN	B-PP	O
low	low	JJ	B-NP	O
100	100	CD	I-NP	O
's	's	POS	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
zantac	zantac	NN	B-NP	O
,	,	,	O	O
NGSL	NGSL	NN	B-NP	O
prn	prn	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
on	on	IN	B-PP	O
HCTZ	HCTZ	NN	B-NP	B-protein
and	and	CC	I-NP	O
vioxx	vioxx	NN	I-NP	O
usual	usual	JJ	I-NP	O
meds	med	NNS	I-NP	O
.	.	.	O	O

Pt	Pt	NN	B-NP	O
.	.	.	O	O

was	be	VBD	B-VP	O
discharged	discharge	VBN	I-VP	O
home	home	NN	B-NP	O
2/16	2/16	CD	I-NP	O
after	after	IN	B-PP	O
the	the	DT	B-NP	O
test	test	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
will	will	MD	B-VP	O
follow	follow	VB	I-VP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr.	Dr.	NNP	B-NP	O
Tait	Tait	NNP	I-NP	O
,	,	,	O	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
referral	referral	JJ	B-ADJP	O
to	to	TO	B-PP	O
cardiologist	cardiologist	NN	B-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
suggest	suggest	VBP	B-VP	O
sleep	sleep	JJ	B-NP	O
study	study	NN	I-NP	O
given	give	VBN	B-VP	O
body	body	NN	B-NP	O
habitus	habitus	NN	I-NP	O
,	,	,	O	O
snoring	snoring	NN	B-NP	O
,	,	,	O	O
and	and	CC	O	O
?	?	.	O	O

adequate	adequate	JJ	B-NP	O
oxygenation	oxygenation	NN	I-NP	O
.	.	.	O	O

ADDITIONAL	ADDITIONAL	JJ	B-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
You	You	PRP	B-NP	O
have	have	VBP	B-VP	O
had	have	VBN	I-VP	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
concerning	concern	VBG	I-VP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
heart	heart	NN	I-NP	O
attack	attack	NN	I-NP	O
.	.	.	O	O

Your	Your	PRP$	B-NP	O
blood	blood	NN	I-NP	O
lab	lab	NN	I-NP	O
tests	test	NNS	I-NP	O
show	show	VBP	B-VP	O
that	that	IN	B-SBAR	O
you	you	PRP	B-NP	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
have	have	VB	I-VP	O
a	a	DT	B-NP	O
heart	heart	NN	I-NP	O
attack	attack	NN	I-NP	O
.	.	.	O	O

Your	Your	PRP$	B-NP	O
stress	stress	NN	I-NP	O
test	test	NN	I-NP	O
was	be	VBD	B-VP	O
abnormal	abnormal	JJ	B-ADJP	O
but	but	CC	O	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
treated	treat	VBN	I-VP	O
by	by	IN	B-PP	O
medications	medication	NNS	B-NP	O
.	.	.	O	O

You	You	PRP	B-NP	B-protein
should	should	MD	B-VP	O
cont	cont	VB	I-VP	O
.	.	.	O	O

your	your	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
,	,	,	O	O
and	and	CC	O	O
also	also	RB	B-VP	O
take	take	VBP	I-VP	O
atenolol	atenolol	NN	B-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
,	,	,	O	O
zantac	zantac	NN	B-NP	O
,	,	,	O	O
zocor	zocor	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
once/day	once/day	RB	B-ADVP	O
at	at	IN	B-PP	O
night	night	NN	B-NP	O
for	for	IN	B-PP	O
your	your	PRP$	B-NP	O
high	high	JJ	I-NP	O
cholesterol	cholesterol	NN	I-NP	O
,	,	,	O	O
lis	lis	NN	B-NP	O
in	in	IN	B-PP	O
addition	addition	NN	B-NP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
baby	baby	NN	I-NP	B-protein
aspirin	aspirin	NN	I-NP	I-protein
-LRB-	-LRB-	HYPH	B-NP	I-protein
81	81	CD	I-NP	I-protein
mg	mg	NN	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
once	once	RB	O	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
.	.	.	O	O

Call	Call	NNP	B-NP	O
Dr.	Dr.	NNP	I-NP	O
Stichter	Stichter	NNP	I-NP	O
to	to	TO	B-VP	O
set	set	VB	I-VP	O
up	up	RP	B-PRT	O
a	a	DT	B-NP	O
folllow	folllow	NN	I-NP	O
up	up	RP	B-PRT	O
appointment	appointment	NN	B-NP	O
within	within	IN	B-PP	O
1	1	CD	B-NP	O
wk	wk	NN	I-NP	O
,	,	,	O	O
you	you	PRP	B-NP	O
may	may	MD	B-VP	O
need	need	VB	I-VP	O
to	to	TO	I-VP	O
see	see	VB	I-VP	O
a	a	DT	B-NP	O
cardiologist	cardiologist	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
have	have	VBP	B-VP	O
a	a	DT	B-NP	O
sleep	sleep	JJ	I-NP	O
study	study	NN	I-NP	O
.	.	.	O	O

Return	Return	NN	B-NP	O
if	if	IN	B-SBAR	O
chest	chest	NN	B-NP	O
pain	pain	NN	I-NP	O
worsens	worsen	NNS	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
CASTANADA	CASTANADA	NN	B-NP	B-protein
,	,	,	O	O
ALPHONSO	ALPHONSO	NN	B-NP	B-protein
ELMO	ELMO	NN	I-NP	I-protein
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
UM99	UM99	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10/1/01	10/1/01	CD	I-NP	O
@	@	SYM	O	O
02	02	CD	B-NP	O
:	:	SYM	I-NP	O
20	20	CD	I-NP	O
PM	PM	NN	I-NP	O
******	******	SYM	B-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

